Document Detail

Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer.
MedLine Citation:
PMID:  20039074     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: Phase angle (PA), determined by bioelectrical impedance analysis (BIA), has been considered as a prognostic factor in several clinical conditions. The purpose of this study is to investigate PA, after adjusting for sex and age (standardized phase angle; SPA) as a prognostic factor for survival in cancer patients.
METHODS: A prospective study was conducted in 195 patients before the first chemotherapy course. BIA was performed in all patients and SPA was calculated. The Kaplan-Meier method was used to calculate survival. The Cox regression method was used to evaluate the independent prognostic effect of PA after adjustment for other variables.
RESULTS: Patients with SPA < -1.65 had a smaller survival rate than those with SPA ≥ -1.65 (p < 0.001). Using Cox regression, the mortality rate was higher in patients with SPA < -1.65 (RR 3.12 CI: 2.03-4.79; p < 0.001). After multivariate analysis, patients with PA < -1.65 still presented a higher mortality rate (RR 2.35 CI: 1.41-3.90; p = 0.001).
CONCLUSIONS: The present study demonstrates that PA, used as SPA, is an independent prognostic indicator in this group of cancer patients receiving chemotherapy treatment even after adjustment for other prognostic variables.
Silvana Iturriet Paiva; Lúcia R Borges; Denise Halpern-Silveira; M Cecília F Assunção; Aluisio J D Barros; M Cristina Gonzalez
Related Documents :
23824644 - Dna methylation in tumour and normal mucosal tissue of head and neck squamous cell carc...
12061944 - Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
7934714 - Using markov processes to describe the prognosis of hiv-1 infection.
2358204 - Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed...
23824644 - Dna methylation in tumour and normal mucosal tissue of head and neck squamous cell carc...
23369684 - Which drug, and when, for patients with braf-mutant melanoma?
Publication Detail:
Type:  Journal Article     Date:  2009-12-29
Journal Detail:
Title:  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer     Volume:  19     ISSN:  1433-7339     ISO Abbreviation:  Support Care Cancer     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2011-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9302957     Medline TA:  Support Care Cancer     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  187-92     Citation Subset:  IM    
Post-graduate Program, Health and Behaviour, Catholic University of Pelotas, Rua Porto Alegre, 492, 96090-520, Pelotas, RS, Brazil,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single-port laparoscopic cholecystectomy: initial experience.
Next Document:  Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.